Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Subject "lonkkanivelen kasvuhäiriö"

Sort by: Order: Results:

  • Holopainen, Saila (2019)
    Canine hip dysplasia (CHD) is a complex developmental orthopedic disorder particularly common in large size breeds. CHD is characterized by the development of a loose and incongruent hip joint. Affected dogs often suffer from secondary osteoarthritis. Radiographic examination reveals flattening of the femoral head and joint widening. An analogous disorder exists in humans. CHD is inherited quantitatively with suggested involvement of the genes of major effect. Genetic studies utilizing dense SNP arrays have revealed few candidate loci and genes for CHD, including the intronic deletion variant of fibrillin 2 (FBN2) gene in Labrador Retriever breed. FBN2 is a promising candidate gene having a functional role in bone and joint development. Therefore, the objective of this study was to investigate the role of FBN2 in the development of CHD in the Finnish dog population and in additional breeds. The specific aims included establishment of well-phenotyped cohorts of samples from four high-risk breeds, namely Labrador Retriever, Golden Retriever, German Shepherd dog and Bernese Mountain Dog and the assessment of the presence and prevalence of the FBN2 deletion in the Finnish dog population affected by CHD. The study cohorts established here will be later utilized also in genome-wide association studies to identify additional CHD loci. Altogether 220 dogs, out of which 53 were Labrador Retrievers, 41 Golden Retrievers, 79 German Shepherd dogs and 47 Bernese Mountain Dogs, were included in the case-control study. For the German Shepherd dogs, the hip status of each dog was further confirmed of by screening the radiographs available from the Finnish Kennel Club archive. All dogs were genotyped by fragment analysis for the FBN2 deletion. The results revealed the presence of the deletion in all four breeds with highest prevalence in the Retriever breeds, in which the deletion haplotype was more common than the wild type. In our study, all CHD-affected dogs in the Labrador Retriever breed had at least one copy of the deletion allele. However, since the deletion allele was common also in the unaffected Labrador Retrievers, no statistically significant allelic association with the deletion and CHD was detected in statistical analysis. In the three other breeds, no association in statistical analysis was found either. Thus, the previously reported positive allelic association between the intronic deletion in the FBN2 gene and CHD was not replicated. Larger genome-wide studies are warranted to identify the major effect CHD loci.